2019 Meeting Session Presentations

Home > Meetings > Past Annual Meetings > 2019 Meeting Session Presentations

Plenary sessions

Plenary Session 1: Digital Health: Science Fact, Not Science Fiction
Chair: Ian Olver, Australia
Digital Health and Oncology: Towards Connected Cancer Care – Sangeeta Agarawal, USA
Overview of Artificial Intelligence (AI) – Alice Landis-McGrath, USA
Overview of Virtual Reality, Augmented Reality and Wearables – David Rhew, USA

Plenary Session 2: New Treatments, New Toxicities
Chair: Rajesh Lalla, USA
Patient-Reported Outcomes (PRO-CTCAE) – Ethan Basch, USA
CAR T-Cell Therapy Toxicity – Lori Muffly, USA
New Radiotherapy Modalities – Sue Yom, USA

Plenary Session 3: Sexual Health: Treatment Strategies
Chair: Hope Rugo, USA
Sexual Problems in Male Cancer Patients: An Overview – John Mulhall, USA
Sexual Problems in Female Cancer Patients – Tami Rowen, USA
Oncofertility – Francesca Duncan, USA

Parallel sessions

Parallel Session 01: Emerging Themes
Chairs: Florian Scotte, France, Tamura Kazuo, Japan
Microbiome: How It Matters – Rachel Gibson, Australia
The Truth Is Out There! Untangling the Evidence Around the Anticancer Effects of Anticoagulants – S. Noble, United Kingdom
The Consequences of Erectile Dysfunction and Other Sexual Changes After Prostate Cancer: A Comparison of Gay/Bisexual and Heterosexual Men – J. Ussher, Australia
Enteric Nervous System Toxicity Underlying Gastrointestinal Side-effects of Chemotherapy: Mechanisms and Potential Treatments – K. Nurgali, Australia

Parallel Session 02: Implementing the MASCC Cancer-Related Fatigue Treatment Guidelines for the Younger and Geriatric Population
Chairs: Karen Mustian, USA, Stephen Samuel, India
Implementing Psychosocial and Integrative Therapies for the Treatment of Cancer-Related Fatigue – Karen Mustian, USA
Strategies to Implement Exercise as a Treatment Modality to Manage Cancer-Related Fatigue – Stephen Samuel, India
Strategies to Implement Pharmacological and Nutraceutical Interventions for the Management of Cancer-Related Fatigue – Sriram Yennu, USA
Higher Levels of Acute and Chronic Stress Are Associated with Worse Morning and Evening Fatigue Profiles in Oncology Outpatients Receiving Chemotherapy – K. Kober, USA
The Promotion of Exercise Oncology as a Standard Part of Clinical Practice – K. Wonders, USA

Parallel Session 03: Sexual Health in Head and Neck Cancer
Chairs: Cherry Estilo, USA, Deborah Saunders, Canada
Head and Neck Cancer and Sexuality in the Era of HPV: Common Patient Questions and Answers – Eleni Rettig, USA
Body Image and Sexuality Research in Head and Neck Cancer – Bethany Rhoten, USA
Approaches to Interventions and Management Strategies of Sexual Dysfunction in Head and Neck Cancer – Karl Torbicki, Canada
Understanding Suicide Rate, Risk Factors and Trends Among Head and Neck Cancer Survivors – Nosayaba Osazuwa-Peters, USA

Parallel Session 04: Digital Health in Action
Chairs: Declan Walsh, USA, Anna Boltong, Australia
Teleoncology – Ian Olver, Australia
Symptom Assessment of Cancer Patients – Christine Miaskowski, USA
Digital Health: The Challenges – Jo Armes, United Kingdom
Efficacy of an E-health Self-Management Application ‘Oncokompas’ to Support Cancer Survivors to Obtain Optimal Supportive Care – Results of a Randomized Controlled Trial – A. Van Der Hout, The Netherlands
Does AI Increase Closeness or Decrease It? Clinician VS Patient Viewpoint – S. Agarawal, USA

Parallel Session 05: When Carers Need Care: Burnout in Cancer Healthcare Providers and Caregivers
Chairs: Bogda Koczwara, Australia, Jason Freedman, USA
Juggling Career and Family While Avoiding Burnout: The Challenge of Pediatric Oncology – Andrea Orsey, USA
Burnout in Palliative Care: When You Are a Survivor and Carer – Redwing Keyssar, USA
Why Physician Wellness Matters and Strategies to Reduce Burnout – Lidia Schapira, USA
The Perceptions of Parental Illness Questionnaire-cancer: An Instrument to Assess Illness Perceptions Among Young People Who Have a Parent With Cancer  – C. Fletcher, Australia
Implementing Psycho-social Distress Screening and Intervention Program in Pediatric Oncology – A. Mohamed, USA

Parallel Session 06: Mucositis Management: Systematic Review – One Goal, Various Approaches
Chairs: Paolo Bossi, Italy, Karis Cheng, Singapore
WALT: The Case of PBM for Mucositis – Praveen Arany, USA
Blautia Luti Regulates Gastrointestinal Toxicity in Cancer Patients Receiving Standard Dose Chemotherapy – Hanna Wardill, The Netherlands

Parallel Session 07: Updates in Hemostasis
Chairs: Carmen Escalante, USA, Paz Fernández Ortega, Spain
Empowering Cancer Patients for Non-pharmacological Primary Prevention and Early Recognition of Cancer-Associated Venous Thromboembolism (VTE): The Empatic-CP Survey – C. Font, Spain
The Safety and Efficacy of Oral Edoxaban Administration Without Initial Heparin Therapy for Venous Thromboembolism in Cancer Patients – R. Kogawa, Japan
Laboratory Biomarkers Predictive of VTE Risk – Howard Liebman, USA
Digital Apps to Manage Anticoagulants and Control Symptoms – Judy Phillips, USA
Anticoagulation for Venous Thromboembolism in Special Populations (Obesity, Underweight, Pregnancy, Renal Failure) – Cristhiam Rojas Hernandez, USA

Parallel Session 08: New Strategies for Managing Neurotoxic Treatment-Related Complications
Chairs: Maryam Lustberg, USA, Katherine Peters, USA
Emerging Targets and Pathways in Chemotherapy-Associated Cognitive Impairment – Alex Chan, Singapore
Novel Therapeutics for Chemotherapy-Induced Neuropathy – Charles Loprinzi, USA
A Randomized Assessor-blinded Wait-list Controlled Trial to Assess the Effectiveness and Cost-effectiveness of Acupuncture in the Management of Chemotherapy-induced Peripheral Neuropathy – A. Molasiotis, Hong Kong S.A.R.
Neuromodulation as a Treatment for Chemotherapy-Induced Neuropathy – Sarah Prinsloo, USA
Prevention of Oxaliplatin-induced Peripheral Neuropathy (OIPN): Randomized Placebo-Controlled Trial Results Investigating Efficacy and Safety of a Recombinant Soluble Human Thrombomodulin (ART-123) – Y. Uchida, Japan

Parallel Session 09: The Changing Face of Febrile Neutropenia
Chair: Bernardo L. Rapoport, South Africa
Febrile Neutropenia: Symptoms, Diagnosis, Treatment, and Best Practice – Bernardo L. Rapoport, South Africa
Treatment of Neutropenia in High-Risk Patients Including Acute Leukemia and Bone Marrow Transplants – Tim Cooksley, United Kingdom
Positive Effects of Trilaciclib on Patient Myelosuppression-related Symptoms and Functioning: Results From Three Phase 2 Randomized, Double-blind, Placebo-controlled Small Cell Lung Cancer Trials – S. Morris, USA

Parallel Session 10: Let’s Talk About Sex
Chairs: Andrea Orsey, USA, Jason Freedman, USA
Sexual and Reproductive Health of Adolescent and Young Adult Patients – Natasha Frederick, USA
Sexual Health and Preparedness in Survivors of Childhood Cancer: The Child-to-Adult TransitionSexual Dysfunction in Adolescent and Young Adult Patients and Survivors – Leslie Schover, USA
Needs for Information and Support About Sexuality-related Issues of Adolescent and Young Adult Cancer Patients: Room for Improvement? – L.F. Albers, The Netherlands
The Veil of Cancer Symptoms in Children: Symptoms We Know About Are Not the Same as the Ones That Cause Distress – P. Yates, School of Nursing

Parallel Session 11: Complications of Immunotherapy
Chairs: Bernardo L. Rapoport, South Africa, Mario Lacouture, USA
Intro: Complications of Immunotherapy – Mario Lacouture, USA
Basic Mechanisms – Bernardo L. Rapoport, South Africa
Overview of Recommendations on Immune-Related Adverse Events – Michael Postow, USA
Emergencies – Tim Cooksley, United Kingdom
GI Toxicities – Michael Dougan, USA
Rheumatological Toxicities – Anne Bass, USA
Renal Toxicities – Jean Klastersky, Belgium

Parallel Session 12: Opioids for Cancer Pain – Keep Calm and Carry On?
Chairs: Gregory Crawford, Australia, David Hui, USA
Opioids for Cancer Pain – What Is the Evidence? – Mellar Davis, USA
Opioid Addiction in Cancer Patients: Prevention and Management – Declan Walsh, USA
Management of Opioid-Induced Bowel Dysfunction – Andrew Davies, United Kingdom
An Investigation of the Sensitivity of the Rome IV Criteria for Opioid-induced Constipation – C. Leach, United Kingdom
The Effect of Abdominal Massage in Managing Opioid-induced Constipation – D. Yildirim, Turkey

Parallel Session 13: Cancer Survivorship Across the Life Cycle
Chairs: Lidia Schapira, USA, Bogda Koczwara, Australia
Pediatric and Adolescent and Young Adults (AYA) Cancer Survivors – Faith Gibson, United Kingdom
Adult Cancer Survivors – Michael Jefford, Australia
GeriOnc Cancer Survivors – William Dale, USA
Symptom Clusters in Cancer Survivors – M. Mazor, USA
Employment and Financial Challenges Faced by Adolescent and Young Adult (AYA) Cancer Survivors: A Qualitative Study – C.J. Tan, Singapore

Parallel Session 14: Cancer Survivorship (Debate): Every Cancer Survivor Must Have a Written Survivorship Care Plan
Chair: Lidia Schapira, USA
Every Cancer Survivor Must Have a Written Cancer Survivorship Care Plan – Bogda Koczwara, Australia
Enrique Soto-Perez-de-Celis, Mexico
Deborah Mayer, USA
Bogda Koczwara, Australia
Michael Jefford , Australia
Faith Gibson , United Kingdom
William Dale , USA

Parallel Session 15: The ABCs of Palliative Cancer Care in the Digital Age: Analytics, Best Practices, and Criteria for Referral
Chairs: Egidio Del Fabbro, USA, David Hui, USA
Advances in Anorexia-Cachexia Assessments: The Role of Artificial Intelligence and Smartphones – Egidio Del Fabbro, USA
Best Practices: Optimizing Supportive Care Interventions in Electronic Medical Records – Janet Abrahm, USA
Criteria for Referral: Standardizing Palliative Care Referral with Automatic Triggers – David Hui, USA
Phase 2 Trial of Symptom Screening With Targeted Early Palliative Care (STEP) for Patients With Advanced Cancer – Zimmermann, Canada
Early and Systematic Integration of Palliative Care in Multidisciplinary Oncology Care: A Randomized Controlled Trial – G. Vanbutsele, Belgium

Parallel Session 16: Sexual Health: A Multi-dimensional Problem
Chairs: Penelope Schofield, Australia, Debra Barton, USA
Sexual Problems in Cancer Patients: An Introduction – Debra Barton, USA
Overcoming the Barriers – Shari Goldfarb, USA
Sexual Issues in Partners of Cancer Patients – J. Ussher, Australia
Discussing Sexuality in Cancer Care: What Information Do Patients Need? – L.F. Albers, The Netherlands
Predictors of Women’s Self-efficacy to Communicate With Their Partner About Sex and Intimacy After Cancer Treatment – E. Arthur, USA

Parallel Session 17: The Changing Face of Palliative Care
Chairs: Gregory Crawford, Australia, Eric Roeland, USA
What Do We Mean by Palliative Care? – Mellar Davis, USA
The Evidence Base for “Early” Palliative Care – Eric Roeland, USA
How Should Palliative Care Services Integrate into Oncology Services? – David Hui, USA
The Enhanced Supportive Care Programme: Improving Access to Supportive and Palliative Care in the Cancer Centre – R. Berman, United Kingdom
The Effectiveness and Cost-effectiveness of Hospital Palliative Care for Adults With Advanced Disease: A Systematic Review – S. Bajwah, United Kingdom

Parallel Session 18: Controversial Issues in Antiemetic Control
Chairs: Rita Wickham, USA, Mitsue Saito, Japan
Introduction – Rita Wickham, USA
Are There Strategies to Improve Antiemetic Access? – Mitsue Saito, Japan
Olanzapine, Do the Guidelines Have It Right? – David Warr, Canada
Pharmacogenomics in the Management of Chemotherapy-Induced Nausea and Vomiting – Sandip Mukhopadhyay, India
Alterations in Patterns of Gene Expression and Perturbed Pathways in the Gut-brain Axis Are Associated With Chemotherapy-induced Nausea – K. Singh, USA
US Physician Concordance with Update to Guidelines Classifying Carboplatin AUC ≥ 4 as Highly Emetogenic Chemotherapy (HEC) – R. Navari, USA

Parallel Session 19: Hot Topics in Palliative Care
Chairs: Carla Ida Ripamonti, Italy, Simon Noble, United Kingdom
VTE in Advanced Cancer – Simon Noble, United Kingdom
De-prescribing in Palliative Care – Jo Thompson, United Kingdom
Management of “Terminal Agitation”: Evidence Versus Pragmatism – Gregory Crawford, Australia
How did the Introduction of Medical Assistance in Dying Impacted Palliative Care in Canada? – A. Al-Awamer, Canada
Integrating Medical Cannabis Within a Quaternary Oncology Center: The Cannabis Pilot Project at the McGill University Health Centre – A. Dr Vigano, Canada

Parallel Session 20: Psychosocial and Functional Consequences of Skeletal Toxicity
Chairs: Lidia Schapira, USA, Beatrice Edwards, USA
Epidemiology of Bone Health Issues in Patients with Cancer – Beatrice Edwards, USA
Functional and Psychosocial Consequences of Fractures – Nelson Watts, USA
Clinical Guidelines for the Management of Bone Health in Patients with Cancer – Matti Aapro, Switzerland
Pain Flare-Effect Prophylaxis With Corticosteroids on Bone Radiotherapy Treatment: A Systematic Review – Fabregat Franco, Spain

Young investigators parallel session

Chairs: Joanne Bowen, Australia, Joel Epstein, USA
Reflections of an Experienced Investigator – Joel Epstein, USA
Gabapentin Mitigates Neuropsychiatric Symptoms in Patients Undergoing Concurrent Chemo-Radiation for Head and Neck Cancer: Interim Results from a Randomized Trial – D. Smith, USA
Fixed-Dose 7.5 mg Rasburicase Is Safe and Cost-Effective in Preventing Tumour Lysis Syndrome in Adult Haematology Patients at University College London Hospitals (UCLH) NHS Trust – R. Burgoyne, United Kingdom
Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy – S. Chow, Canada
Association of Frailty With Emotional Health of Older Patients With Advanced Cancer: A University of Rochester NCI Community Oncology Research Program Geriatric Assessment Trial – N. Gilmore, USA
Treatment-Related Mortality in Children with Acute Lymphoblastic Leukemia in a Low-Middle-Income Country – R. Ul-Ain, Pakistan

ISOO parallel session

ISOO Parallel Session 1: Smoking Cessation
Chair: Siri Beier-Jensen, Denmark
Myth Busters of Clinical Tobacco Intervention in the Oncology Setting and Professional Perceptions – Deborah Saunders, Canada
Cancer Patient Awareness and Attitudes about Tobacco Cessation – Lawson Eng, Canada

ISOO Parallel Session 2: Lymphedema and Fibrosis in Head and Neck Cancer Survivors: Biology and Clinical Manifestations
Chair: Barbara Murphy, USA
Lymphedema in the Head and Neck Cancer Population: Incidence, Impact and Measurement – Jie Deng, USA

ISOO Parallel Session 3: Dysphagia in Head and Neck Cancer Patients: Evaluation and Management
Chair: Deborah Saunders, Canada
Acute and Long-Term Swallow Dysfunction in Head and Neck Cancer Patients: Evaluation and Management – Katherine Hutcheson, USA – ONLINE Presentation
Case Presentation with Panel Discussion
Panelists: Katherine Hutcheson, USA, John Wu, Canada, Barbara Murphy, USA, Deborah Hawkins, USA

Joint sessions

ISNCC / MASCC Joint Session: Multidisciplinary Team (MDT) Working
Chairs: Christine Miaskowski, USA, Patsy Yates, Australia2
Cancer MDTs: Do They Make a Difference? – Jo Thompson, United Kingdom
Dealing with Conflict within MDTs – Penelope Schofield, Australia
Empowering Patients and Carers – Patsy Yates, Australia

EONS / MASCC / ONS Joint Session: How Patients Feel Really Matters – Challenges and Opportunities for Oncology Nursing in a Digital Era
Chairs: Annie Young, United Kingdom, Andreas Charalambous, Cyprus, Pamela Ginex, USA
Effective Patient-Provider Communication – Pamela Ginex, USA
Outpatient Experiences with Web-Based Applications to Monitor Their Symptoms (EONS 1) – Wendy Oldenmenger, The Netherlands
Personalizing Virtual Environments through Immersive Virtual Reality: The Patient Perspective on Achieving the Goal of Patient-Centeredness (EONS 2) – Andreas Charalambous, Cyprus
Using Patient-Reported Outcomes for Patient Decision-Making (ONS) – Donna Berry, USA
Using a Community-based, Nurse-led Cancer Information and Support Line to Deliver Phone-based Supportive Care Interventions: An Australian Experience (MASCC) – Katherine Lane, Australia

AFSOS / MASCC / NICSO Joint Session: Developing Supportive Care in Cancer: A European Perspective
Chairs: Carla Ida Ripamonti, Italy, Florian Scotte, France
Dedicated Supportive Care Units (SCUs): An Italian Model – Carla Ida Ripamonti, Italy
Dedicated SCUs: A French Perspective – Florian Scotte, France
Supportive Care Teams Outside the Hospital: A French Model – Mario Di Palma, France
Models of Education in Supportive Care – Andrea Antonuzzo, Italy
NICSO Research Program – Paolo Bossi, Italy
AFSOS Research Program – Ivan Krakowski, France

ISOPP / MASCC Joint Session: Biosimilars
Chairs: Matti Aapro, Switzerland, Hope Rugo, USA
Biosimilars in Supportive Care – Emma Foreman, United Kingdom
Current Guidelines on the Use of Biosimilars – Harbans Dhillon, Malaysia
Biosimilars in Oncology – Hope Rugo, USA

JASCC / MASCC Joint Session: Cancer Survivorship in Adolescents and Young Adults (AYA)
Chairs: Mitsue Saito, Japan, Margaret Fitch, Canada
Overview of the Issues – Michael Feuerstein, USA
The Impact of Cancer on Adolescent and Young Adult Survivors’ Work-Related Issues – Miyako Takahashi, Japan
Follow-up of AYA Cancer Survivors – Margaret Fitch, Canada
Ongoing Trials: AYA Cancer Survivors in Asia – Alex Chan, Singapore

MASCC / SIOG Joint Session: Managing the Oldest and Frailest Oncology Patients
Chairs: Annie Young, United Kingdom, Christopher Steer, Australia
Geriatric Assessment in Day-to-Day Practice – Rana Jin, Canada
Optimizing Quality of Life – William Dale, USA
Geriatric Oncology in Low and Middle-Income Countries – Enrique Soto-Perez-de-Celis, Mexico
Association of Polypharmacy and Potentially Inappropriate Medications With Physical Function in Older Patients With Cancer Receiving Chemotherapy: A University of Rochester Nationwide Geriatric Assessment Study – M. Mohamed, USA
Older Cancer Survivors Have a Lower Symptom Burden – B. Quintanilla, USA

Meet the experts

Meet the Experts: Writing for Supportive Care in Cancer
Chairs: Fred Ashbury, Canada, Ian Olver, Australia, Jørn Herrstedt, Denmark
Developing and Submitting Supportive Care Practice Guidelines to MASCC For Approval/Endorsement
Writing for Peer-Reviewed Publication

Meet the Experts: Using Social Media
Chairs: Hannah Wardill, The Netherlands, Ysabella Van Sebille, Australia
Social Media: MASCC’s New Strategic Focus to Enhance the Provision of Supportive Care in Cancer – Ysabella Van Sebille, Australia
Social Media in Healthcare: How to Communicate With Impact – Marie Ennis O’Connor, Ireland
Lessons Learned: How #GeriOnc and ASCO Are Leading the Way in Social Media Engagement – Enrique Soto-Perez-de-Celis, Mexico
“How Many Likes Did We Get?”: The Use of Social Media in Cancer NGOs: The Cancer Council Experience – Katherine Lane, Australia

Supported Symposia

Scalp Cooling – Supported Symposium Organized by Paxman and Dignitana
Chairs: Frances Boyle, Australia, Hope Rugo, USA
Impact of Alopecia on Quality of Life – Frances Boyle, Australia
Cooling for Prevention of Chemotherapy-induced Alopecia – The Evidence – Hope Rugo, USA
Scalp Cooling for Prevention of Chemotherapy-induced Alopecia – The “Real World” Experience – Corina van den Hurk, The Netherlands
Endocrine Therapy-Induced Alopecia – Mario Lacouture, USA
Patient’s Perspective – Jaime Zapata, USA

Study group meetings

Antiemetics – Agenda

Bone & Musculoskeletal – Agenda


Geriatrics – Agenda , Study Group Survey

Mucositis – Agenda

Palliative Care – Agenda


Survivorship – Agenda